Vaccine-Preventable Diseases

COVID-19 Vaccine Factsheets

 

COVID-19 Vaccine Videos  

 

COVID-19 Vaccine Posters: One Visit. Two Shots. 

 

 

COVID-19 Vaccine Social Media Images: Myth-busting Mondays

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 COVID-19 Vaccine Social Media Images: One Visit. Two Shots. 

 

 

 

 

COVID-19 vaccine awareness posters and social media images 

 

 

NACI Guidance

• Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid). National Advisory Committee on Immunization (NACI). 08 March 2024.

• Summary of National Advisory Committee on Immunization (NACI) Statement of March 8, 2024: Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid). National Advisory Committee on Immunization (NACI). 08 March 2024.

• Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19. National Advisory Committee on Immunization (NACI). 12 January 2024.

• Summary of NACI Statement of January 12, 2024: Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19. National Advisory Committee on Immunization (NACI). 12 January 2024.
• Updated chapter – COVID-19 vaccines: Canadian Immunization Guide. Public Health Agency of Canada. 05 December 2023.
• Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19. National Advisory Committee on Immunization. 27 October 2023.
• Summary of National Advisory Committee on Immunization (NACI) Statement of October 27, 2023: Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19. National Advisory Committee on Immunization. 27 October 2023.
• COVID-19 Vaccines: Canadian Immunization Guide. Public Health Agency of Canada. Updated 20 October 2023.
• Addendum to the guidance on the use of COVID-19 vaccines in the fall of 2023. National Advisory Committee on Immunization (NACI). 12 September 2023.
• Summary of National Advisory Committee on Immunization (NACI) Supplemental Statement of September 12, 2023: Addendum to the guidance on the use of COVID-19 vaccines in the fall of 2023. National Advisory Committee on Immunization (NACI). 12 September 2023.
• Guidance on the use of COVID-19 vaccines in the fall of 2023. National Advisory Committee on Immunization (NACI). 11 July 2023.
• Summary of National Advisory Committee on Immunization (NACI) Statement of July 11, 2023: Guidance on the use of COVID-19 vaccines in the fall of 2023. National Advisory Committee on Immunization (NACI). 11 July 2023.
• Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series. National Advisory Committee on Immunization (NACI). 09 June 2023.
• Summary of National Advisory Committee on Immunization (NACI) Statement of June 9, 2023: Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series. National Advisory Committee on Immunization (NACI). 09 June 2023.
• Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series. National Advisory Committee on Immunization (NACI). 09 June 2023.
• COVID-19 vaccine: Canadian Immunization Guide. Public Health Agency of Canada. Updated 22 March 2023.
• Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19. National Advisory Committee on Immunization (NACI). 03 March 2023.
• Summary of National Advisory Committee on Immunization (NACI) Statement of March 3, 2023: Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19. National Advisory Committee on Immunization (NACI). 03 March 2023.
• Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023. National Advisory Committee on Immunization (NACI). 20 January 2023.
• Summary of National Advisory Committee on Immunization (NACI) Statement of January 20, 2023: Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023. National Advisory Committee on Immunization (NACI). 20 January 2023.
• Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration. National Advisory Committee on Immunization (NACI). 09 December 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of December 9, 2022: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration. National Advisory Committee on Immunization (NACI). 09 December 2022.
• Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults. National Advisory Committee on Immunization (NACI). 03 November 2022.
• Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age. National Advisory Committee on Immunization (NACI). 21 October 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age. National Advisory Committee on Immunization (NACI). 21 October 2022.
• Updated guidance on COVID-19 vaccine booster doses in Canada. National Advisory Committee on Immunization (NACI). 07 October 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of October 7, 2022: Updated guidance on COVID-19 vaccine booster doses in Canada. National Advisory Committee on Immunization (NACI). 07 October 2022.
• Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding. National Advisory Committee on Immunization (NACI). 09 September 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of September 9, 2022: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding. National Advisory Committee on Immunization (NACI). 09 September 2022.
• Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines. National Advisory Committee on Immunization (NACI). 01 September 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of September 1, 2022: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines. National Advisory Committee on Immunization (NACI). 01 September 2022.
• Recommendations on the use of of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age. National Advisory Committee on Immunization (NACI). 19 August 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of August 19, 2022: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age. National Advisory Committee on Immunization (NACI). 19 August 2022.
• Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age. National Advisory Committee on Immunization (NACI). 14 July 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age. National Advisory Committee on Immunization (NACI). 14 July 2022.
• Statement: Health Canada authorizes use of Moderna COVID-19 vaccine in children 6 months to 5 years of age. Health Canada. 14 July 2022.
• Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada. National Advisory Committee on Immunization (NACI). 29 June 2022.
• Summary of National Advisory Committee (NACI) Statement of June 29, 2022: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada. National Advisory Committee on Immunization (NACI). 29 June 2022.
• Summary of updates in the Canadian Immunization Guide of June 21, 2022: Updated guidance on COVID-19 vaccines in Canada. National Advisory Committee on Immunization (NACI). 21 June 2022.
• Updated guidance on a first booster dose of COVID-19 vaccines in Canada. National Advisory Committee on Immunization (NACI). 12 April 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of April 12, 2022: Updated guidance on a first booster dose of COVID-19 vaccines in Canada. National Advisory Committee on Immunization (NACI). 12 April 2022.
• Initial guidance on a second booster dose of COVID-19 vaccines in Canada. National Advisory Committee on Immunization (NACI). 05 April 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of April 5, 2022: Initial guidance on a second booster dose of COVID-19 vaccine in Canada. National Advisory Committee on Immunization (NACI). 05 April 2022.
• Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age. National Advisory Committee on Immunization (NACI). 17 March 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age. National Advisory Committee on Immunization (NACI). 17 March 2022.
• Recommendations on the use of Medicago COVID-19 vaccine (Covifenz). National Advisory Committee on Immunization (NACI). 11 March 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz). National Advisory Committee on Immunization (NACI). 11 March 2022.
• COVID-19: Recommendations for those vaccinated with vaccines not authorized by Health Canada for those staying in Canada to live, work or study. Public Health Agency of Canada. 11 March 2022.
• Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine. National Advisory Committee on Immunization (NACI). 17 February 2022.
• Summary of National Advisory Committee on Immunization (NACI) Statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine. National Advisory Committee on Immunization (NACI). 17 February 2022.
• COVID-19 vaccine: Canadian Immunization Guide. Government of Canada. 09 February 2022.
• Rapid response: Updated guidance on COVID-19 vaccination timing for individuals previously infected with SARS-CoV-2. National Advisory Committee on Immunization (NACI). 04 February 2022.
• Summary of National Advisory Committee on Immunization Rapid Response of February 4, 2022. National Advisory Committee on Immunization (NACI). 04 February 2022.
• Rapid response: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12-17 years of age. National Advisory Committee on Immunization (NACI). 28 January 2022.
• Summary of National Advisory Committee on Immunization Rapid Response of January 28, 2022. National Advisory Committee on Immunization (NACI). 28 January 2022.
• Updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age. National Advisory Committee on Immunization (NACI). 25 January 2022.
• Summary of National Advisory Committee on Immunization Statement of January 25, 2022 – Updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age. National Advisory Committee on Immunization (NACI). 25 January 2022.
• Summary of NACI advice on vaccination with COVID-19 vaccines following myocarditis (with or without pericarditis). National Advisory Committee on Immunization (NACI). 14 January 2022.
• Guidance on booster COVID-19 vaccine doses in Canada – Update December 3, 2021. National Advisory Committee on Immunization (NACI). 03 December 2021.
• Summary of the National Advisory Committee on Immunization (NACI) Statement of December 3, 2021. National Advisory Committee on Immunization (NACI). 03 December 2021.
• Rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines. National Advisory Committee on Immunization (NACI). 03 December 2021.
• Summary of the National Advisory Committee on Immunization (NACI) Rapid Response of December 3, 2021. National Advisory Committee on Immunization (NACI). 03 December 2021.
• Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5-11 years of age. National Advisory Committee on Immunization (NACI). 19 November 2021.
• Summary of the National Advisory Committee on Immunization (NACI) Statement of November 19, 2021 – Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5-11 years of age. National Advisory Committee on Immunization (NACI). 19 November 2021.
• Interim guidance on booster COVID-19 vaccine doses in Canada. National Advisory Committee on Immunization (NACI). 29 October 2021.
• Summary of National Advisory Committee on Immunization (NACI) Statement: Interim guidance on booster COVID-19 vaccine doses in Canada. National Advisory Committee on Immunization (NACI). 29 October 2021.
• Recommendations on the use of COVID-19 vaccines. National Advisory Committee on Immunization (NACI). 22 October 2021.
• Summary of National Advisory Committee on Immunization (NACI) statement: Recommendations on the use of COVID-19 vaccines – update: October 22, 2021. National Advisory Committee on Immunization (NACI). 22 October 2021.
• Quick reference guide on use of COVID-19 vaccines: Overview. Public Health Agency of Canada. 13 October 2021.
• National Advisory Committee on Immunization (NACI) rapid response: Booster dose in long-term care residents and seniors living in other congregate settings. National Advisory Committee on Immunization (NACI). 28 September 2021.
• Summary of National Advisory Committee on Immunization (NACI) rapid response: Booster dose of COVID-19 vaccine in long-term care residents and seniors living in other congregate settings. National Advisory Committee on Immunization (NACI). 28 September 2021.
• National Advisory Committee on Immunization (NACI) rapid response: Additional dose of COVID-19 vaccine in immunocompromised individuals following 1- or 2- dose primary series. National Advisory Committee on Immunization (NACI). 10 September 2021.
• Summary of National Advisory Committee on Immunization (NACI) rapid response: Additional dose of COVID-19 vaccine in immunocompromised individuals following a 1- or 2-dose primary series. National Advisory Committee on Immunization (NACI). 10 September 2021.
• Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age. National Advisory Committee on Immunization (NACI). 27 August 2021.
• COVID-19 Recommendations for those vaccinated with vaccines not authorized by Health Canada for those staying in Canada to live, work or study. Government of Canada. 17 August 2021.
• NACI Rapid Response: Interchangeability of authorized COVID-19 vaccines. National Advisory Committee on Immunization (NACI). 01 June 2021.
• Summary of NACI Rapid Response of June 1, 2021. National Advisory Committee on Immunization (NACI). 01 June 2021.
• Use of Pfizer-BioNTech COVID-19 vaccine in adolescents 12-18 years of age. National Advisory Committee on Immunization (NACI).
• Summary of National Advisory Committee on Immunization Statement of May 18, 2021. National Advisory Committee on Immunization (NACI). 18 May 2021.
• Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply. National Advisory Committee on Immunization (NACI). 07 April 2021.
• Summary of NACI extended dose intervals statement of April 7, 2021. National Advisory Committee on Immunization (NACI). 07 April 2021.
• COVID-19 in Canada: A one-year update on social and economic impacts. Statistics Canada. 11 March 2021.
• Guidance on the prioritization of initial doses of COVID-19 vaccine(s). National Advisory Committee on Immunization (NACI).
• Interim guidance on continuity of immunization programs during the COVID-19 pandemic. National Advisory Committee on Immunization (NACI).
• Recommendations on the use of COVID-19 vaccines. National Advisory Committee on Immunization (NACI).
• Preliminary guidance on key populations for early COVID-19 immunization. National Advisory Committee on Immunization (NACI).
• Planning guidance for administration of COVID-19 vaccine. National Advisory Committee on Immunization (NACI).
• Planning guidance for immunization clinics for COVID-19 vaccines. National Advisory Committee on Immunization (NACI).
• Vaccines and treatments for COVID-19: Vaccine rollout. Government of Canada.
• Coronavirus disease: Guidance documents. Government of Canada.

Additional Resources

• COVID-19 vaccine for children and adolescents. Canadian Paediatric Society Position Statement. 25 September 2023.
• Let’s Talk COVID Vaccines. Institute for Vaccine Safety. Johns Hopkins Bloomberg School of Public Health | Immunize Canada.
• COVID-19 in young children. COVID-19 Vaccine for Kids Under 5 video series. Children’s Healthcare Canada and Solutions for Kids in Pain (SKIP). July 2022.
• Is the COVID-19 vaccine for children under 5 considered experimental? COVID-19 Vaccine for Kids Under 5 video series. Children’s Healthcare Canada and Solutions for Kids in Pain (SKIP). July 2022.
• How soon after a first dose of the COVID-19 vaccine should a child under 5 receive a second dose, and does that change if they have recently been infected with COVID-19? COVID-19 Vaccine for Kids Under 5 video series. Children’s Healthcare Canada and Solutions for Kids in Pain (SKIP). July 2022.
• Is it safer and more effective, in terms of protection from infection and impacts for children younger than 5, to gain immunity from a COVID-19 vaccine, or through a COVID-19 infection? COVID-19 Vaccine for Kids Under 5 video series. Children’s Healthcare Canada and Solutions for Kids in Pain (SKIP). July 2022.
• What do we know about the risks to children younger than 5 of catching COVID-19 and experiencing severe short- or long-term outcomes? COVID-19 Vaccine for Kids Under 5 video series. Children’s Healthcare Canada and Solutions for Kids in Pain (SKIP). July 2022.
• What do we know about the effectiveness of the COVID-19 vaccine for children younger than 5, in terms of preventing infection and severe effects of COVID-19? COVID-19 Vaccine for Kids Under 5 video series. Children’s Healthcare Canada and Solutions for Kids in Pain (SKIP). July 2022.
• All parents want to do what is best for their children, including of course those younger than 5. In terms of COVID-19, what is your best advice, informed by the current state of the science, for these parents? COVID-19 Vaccine for Kids Under 5 video series. Children’s Healthcare Canada and Solutions for Kids in Pain (SKIP). July 2022.
• Is COVID-19 mild for kids? Video by Science Up First. 13 July 2022.
• Kids & Vaccines Town Hall. Science Up First. Recorded 27 January 2022.
• What are the benefits of vaccinating my child against COVID-19? Video by Health Canada. 28 January 2022.
• How are children’s COVID-19 vaccines monitored for safety and side effects? Video by Health Canada. 28 January 2022.
• My child turns 12 soon. Should they wait to receive the dose for ages 12 and up? Video by Health Canada. 28 January 2022.
• Kids and Omicron (recording of virtual town hall). Children’s Hospital of Eastern Ontario (CHEO). 06 January 2022.
• How COVID-19 mRNA vaccines work. Video by Vaccine Makers Project.
• How COVID-19 viral vector vaccines work. Video by Vaccine Makers Project.
• COVID-19: Vaccine safety post-market surveillance. Healthy Canadians.
• Vaccine Ambassador Stories: Hannah (English). Ottawa Public Health.
• Vaccine Ambassador Stories – Sheekoyinka Safiirada Tallaalka COVID-19 Hannah (Somali). Ottawa Public Health.
• Vaccine Ambassador Stories: Félicité (English). Ottawa Public Health.
• Vaccine Ambassador Stories: Félicité (French). Ottawa Public Health.
• #MyWhy on Getting the COVID-19 Vaccine: Dr. Theresa Tam, Chief Public Health Officer of Canada.
• #MyWhy on Getting the COVID-19 Vaccine: Dr. Howard Njoo, Deputy Chief Public Health Officer of Canada.
• #MyWhy on Getting the COVID-19 Vaccine: Dr. Guillaume Poliquin, Acting Vice President, National Microbiology Laboratory.
• #MyWhy on Getting the COVID-19 Vaccine: Dr. Supriya Sharma, Chief Medical Advisor, Health Canada.
• #MyWhy on Getting the COVID-19 Vaccine: Angela Spence-Bédard, Nurse Practitioner.
• #MyWhy on Getting the COVID-19 Vaccine: Dr. Noni E. MacDonald, Professor of Pediatrics, Infectious Diseases.
• #MyWhy on Getting the COVID-19 Vaccine: Dr. Kal Belay, Acute Care and Minimally Invasive General Surgeon.
• Ask the Experts video series: COVID-19 vaccines questions. Government of Canada.
• COVID-19 awareness resources and videos in Indigenous languages. Public Health Agency of Canada, Indigenous Services Canada and various Indigenous organizations.
• Pediatricians discuss vaccines, pregnancy, development and autism (video). 23 December 2021. The Children’s Hospital of Philadelphia (US).
• Vaccine Conversations: Why do unvaccinated people pose a risk to vaccinated people? (video) 10 December 2021. The Children’s Hospital of Philadelphia (US).
• What we know about vaccines, the immune system and autoimmunity (video). 24 November 2021.
• Vaccine Conversations: Vaccines and breastfeeding (video). 24 November 2021. The Children’s Hospital of Philadelphia (US).
• Wondering why you should get the COVID-19 vaccine? Families Against COVID-19 (US).
• Why I got the COVID-19 vaccine: Isabel. Vaccine Education Center, Children’s Hospital of Philadelphia (US).
• Why I got the COVID-19 vaccine: Jason. Vaccine Education Center, Children’s Hospital of Philadelphia (US).
• Why I got the COVID-19 vaccine and what I felt afterward: Ritter. Vaccine Education Center, Children’s Hospital of Philadelphia (US).
• Why I got the COVID-19 vaccine and what I felt afterward: Victoria. Vaccine Education Center, Children’s Hospital of Philadelphia (US).
• Why I got the COVID-19 vaccine and what I felt afterward: Aleshia. Vaccine Education Center, Children’s Hospital of Philadelphia (US).
• Why I got the COVID-19 vaccine: Gilbert. Vaccine Education Center, Children’s Hospital of Philadelphia (US).
• Why I got the COVID-19 vaccine: Kristen. Vaccine Education Center, Children’s Hospital of Philadelphia (US).
• Why I got the COVID-19 vaccine: Paul. Vaccine Education Center, Children’s Hospital of Philadelphia (US).
• Why I got the COVID-19 vaccine: Safa. Vaccine Education Center. Children’s Hospital of Philadephia (US).
• Why I got the COVID-19 vaccine and what I felt afterward: Tyra. Vaccine Education Center, Children’s Hospital of Philadelphia (US).
• COVID-19 Social Media Graphics: #StopTheSpread. National Foundation for Infectious Diseases (US).
• COVID-19 Social Media Graphics: COVID-19 Myths and Facts. National Foundation for Infectious Diseases (US).
• COVID-19 Social Media Graphics: General Myths and Facts. National Foundation for Infectious Diseases (US).
• COVID-19 Social Media Graphics: #StopTheSpread. National Foundation for Infectious Diseases (US).
• COVID-19 Social Media Graphics: COVID-19 Myths and Facts. National Foundation for Infectious Diseases (US).
• COVID-19 Social Media Graphics: General Myths and Facts. National Foundation for Infectious Diseases (US).